VAERS reports by lot

Novartis Vaccines Meningococcal lot ABXC06AA: VAERS reports

21 VAERS reports list lot ABXC06AA as a Novartis Vaccines Meningococcal vaccine, received between 2022-05-27 and 2023-05-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1332%
General / Systemic (non-local)820%
Musculoskeletal615%
Neurological512%
Cardiac / Cardiovascular37%
Gastrointestinal37%
Allergic / Anaphylactic12%
Respiratory12%
Dermatological (non-injection-site)12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan2
Texas2
Washington2
Alabama2
Ohio2
Oklahoma1
New Hampshire1
Puerto Rico1
Indiana1
Massachusetts1
Pennsylvania1
Minnesota1

Reports by month received

2022-051
2022-068
2022-072
2022-083
2022-091
2022-101
2023-042
2023-053

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.